Please assess the completion status of the following clinical trial:

Trial Title: Clinical Trial Tobacco Marijuana

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Individuals must be 18 years or older~2. Individuals must meet criteria for the current Diagnostic and Statistical Manual -IV diagnosis of cannabis abuse or dependence, report use of cannabis on at least 45 of the previous 90 days, and report regular use of tobacco cigarettes or report that their primary administration of cannabis is via blunts or spliffs~3. Individual must indicate that they have at least some interest in quitting tobacco in the next 6 months (rating of 2 or more on a 5-point interest scale)~Exclusion Criteria:~1. Current dependence on alcohol or any drug other than tobacco and cannabis~2. Use of non-tobacco nicotine~3. Current participation in structured treatment for substance abuse~4. Severe psychological distress (e.g., active suicidal plans, psychosis, debilitating panic disorder)~5. Report of a condition that requires seeing a physician before using NRT (e.g., pregnancy or recent heart attack); note: if a participant's physician approves taking NRT, we will consider enrolling them~6. Legal status that would interfere with participation~7. Living with someone currently enrolled in the project~8. Not being fluent in English~9. Not living within 45 miles of the research site

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- CUD Treatment Only (Type: ACTIVE_COMPARATOR): 12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD
- CUD and Tobacco Treatment (Type: EXPERIMENTAL): 12 Week Behavioral Treatment that included weekly computer-assisted counseling and contingency management for CUD, and behavioral counseling and nicotine replacement therapy (NRT) for tobacco

Based on this trial design, predict the completion outcome and termination type (if applicable).